Monash IVF Group Limited
ASX: MVF
Revenue and EBITDA grow steadily on FET cycles and acquisitions.
(Source: TradingView) 3-Month Performance Profile of MVF on a DTF compared to S&P/ASX 200 (XJO).
In FY25, Monash IVF Group reported total revenue of $271.9 million, up 6.7% year-on-year, supported by FET cycle growth, a full-year contribution from the Fertility North acquisition, and stronger
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
